Literature DB >> 24375925

Distinguishing incident and prevalent diabetes in an electronic medical records database.

Ronac Mamtani1, Kevin Haynes, Brian S Finkelman, Frank I Scott, James D Lewis.   

Abstract

PURPOSE: To develop a method to identify incident diabetes mellitus (DM) using an electronic medical records (EMR) database and test this classification by comparing incident and prevalent DM with common outcomes related to DM duration.
METHODS: Incidence rates (IRs) of DM (defined as a first diagnosis or prescription) were measured in 3-month intervals through 36 months after registration in The Health Improvement Network, a primary care database, from 1994 to 2012. We used Joinpoint regression to identify the point where a statistically significant change in the trend of IRs occurred. Further analyses used this point to distinguish those likely to have incident (n = 50 315) versus prevalent (n = 28 337) DM. Incident and prevalent cohorts were compared using Cox regression for all-cause mortality, cardiovascular disease (CVD), diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy. Analyses were adjusted for age, sex, smoking, obesity, hyperlipidemia, hypertension, and calendar year.
RESULTS: Trends in DM IRs plateaued 9 months after registration (p = 0.04). All cause-mortality was increased (hazard ratio (HR) 1.62, 95% CI 1.53-1.70) among patients diagnosed with DM prior to 9 months following registration (prevalent DM) compared to those diagnosed after 9 months (incident DM). Similarly, the risk of DM-related complications was higher in prevalent versus incident DM patients [CVD, HR 2.24 (2.08-2.40); diabetic retinopathy, HR 1.31 (1.24-1.38); diabetic nephropathy, HR 2.30 (1.95-2.72); diabetic neuropathy, HR 1.28 (1.16-1.41)].
CONCLUSION: Joinpoint regression can be used to identify patients with newly diagnosed diabetes within EMR data. Failure to exclude patients with prevalent DM can lead to exaggerated associations of DM-related outcomes.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  bias; cohort studies; diabetes; electronic medical records; incidence; pharmacoepidemiology

Mesh:

Year:  2013        PMID: 24375925      PMCID: PMC3929581          DOI: 10.1002/pds.3557

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  40 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  Diabetes duration and cause-specific mortality in the Verona Diabetes Study.

Authors:  E Brun; R G Nelson; P H Bennett; G Imperatore; G Zoppini; G Verlato; M Muggeo
Journal:  Diabetes Care       Date:  2000-08       Impact factor: 19.112

3.  The Read clinical classification.

Authors:  J Chisholm
Journal:  BMJ       Date:  1990-04-28

4.  Identifying persons with diabetes using Medicare claims data.

Authors:  P L Hebert; L S Geiss; E F Tierney; M M Engelgau; B P Yawn; A M McBean
Journal:  Am J Med Qual       Date:  1999 Nov-Dec       Impact factor: 1.852

5.  Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm.

Authors:  Janet E Hux; Frank Ivis; Virginia Flintoft; Adina Bica
Journal:  Diabetes Care       Date:  2002-03       Impact factor: 19.112

6.  Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates.

Authors:  Steven M Brunelli; Joshua J Gagne; Krista F Huybrechts; Shirley V Wang; Amanda R Patrick; Kenneth J Rothman; John D Seeger
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-03-22       Impact factor: 2.890

7.  Trends in cardiovascular risk factors among people with diabetes in a population based study, Health Survey for England 1994-2009.

Authors:  Shyamalee Samaranayaka; Martin C Gulliford
Journal:  Prim Care Diabetes       Date:  2013-05-16       Impact factor: 2.459

8.  Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease.

Authors:  James D Lewis; Colleen Brensinger; Warren B Bilker; Brian L Strom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002 Apr-May       Impact factor: 2.890

Review 9.  Metformin and the risk of cancer: time-related biases in observational studies.

Authors:  Samy Suissa; Laurent Azoulay
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112

10.  Positive predictive value of a case definition for diabetes mellitus using automated administrative health data in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid study.

Authors:  William V Bobo; William O Cooper; C Michael Stein; Mark Olfson; Jackie Mounsey; James Daugherty; Wayne A Ray
Journal:  BMC Med Res Methodol       Date:  2012-08-24       Impact factor: 4.615

View more
  14 in total

1.  Psoriasis and the risk of diabetes: A prospective population-based cohort study.

Authors:  Marilyn T Wan; Daniel B Shin; Rebecca A Hubbard; Megan H Noe; Nehal N Mehta; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2017-11-08       Impact factor: 11.527

2.  Validation of a coding algorithm for intra-abdominal surgeries and adhesion-related complications in an electronic medical records database.

Authors:  Frank I Scott; Ronac Mamtani; Kevin Haynes; David S Goldberg; Najjia N Mahmoud; James D Lewis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-02-10       Impact factor: 2.890

3.  Influence of comorbidities on the implementation of the fundus examination in patients with newly diagnosed type 2 diabetes.

Authors:  Taichi Kawamura; Izumi Sato; Hiroshi Tamura; Yoko M Nakao; Koji Kawakami
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

4.  Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.

Authors:  Kashif Jafri; Christie M Bartels; Daniel Shin; Joel M Gelfand; Alexis Ogdie
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11-28       Impact factor: 4.794

5.  Association of Itraconazole, a Hedgehog Inhibitor, and Bladder Cancer.

Authors:  Ronac Mamtani; Yu-Xiao Yang; Frank I Scott; James D Lewis; Ben Boursi
Journal:  J Urol       Date:  2016-01-23       Impact factor: 7.450

6.  An algorithm for identification and classification of individuals with type 1 and type 2 diabetes mellitus in a large primary care database.

Authors:  Manuj Sharma; Irene Petersen; Irwin Nazareth; Sonia J Coton
Journal:  Clin Epidemiol       Date:  2016-10-12       Impact factor: 4.790

7.  Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study.

Authors:  Enrique Soto-Pedre; Paul J Newey; John S Bevan; Graham P Leese
Journal:  Endocr Connect       Date:  2017-11       Impact factor: 3.335

Review 8.  Factors influencing the development of primary care data collection projects from electronic health records: a systematic review of the literature.

Authors:  Marie-Line Gentil; Marc Cuggia; Laure Fiquet; Camille Hagenbourger; Thomas Le Berre; Agnès Banâtre; Eric Renault; Guillaume Bouzille; Anthony Chapron
Journal:  BMC Med Inform Decis Mak       Date:  2017-09-25       Impact factor: 2.796

9.  Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study.

Authors:  Manuj Sharma; Irwin Nazareth; Irene Petersen
Journal:  BMJ Open       Date:  2016-01-13       Impact factor: 2.692

10.  Impact of different assumptions on estimates of childhood diseases obtained from health care data: A retrospective cohort study.

Authors:  Osemeke U Osokogu; Alexandra Pacurariu; Mees Mosseveld; Peter Rijnbeek; Daniel Weibel; Katia Verhamme; Miriam C J M Sturkenboom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-04-24       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.